Leslie W. Kreis bought $500k of ACTU
director, owner at ACTUATE THERAPEUTICS, INC.. 71,428 shares at an average of $7.00, traded Jun 27, 2025, filed Jun 30, 2025.
Score components
- +15RoleDirector
- +18Trade size$500k at market
- +10Relative to holdingsHoldings up 57%
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-063992, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 27, 2025 | POpen-market purchase Common Stockindirect: Directly held by Bios 2024 Co-Invest, LP | +71,428 | $7.00 | $500k | 196,428 | Jun 30, 2025 |
| Jun 27, 2025 | POpen-market purchase Warrant (Right to Buy)derivativeindirect: Directly held by Bios 2024 Co-Invest, LP | +71,428 | $0.00 | $0 | 71,428 | Jun 30, 2025 |
Related signals
Other insiders at ACTUATE THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | ACTUsell ACTUATE THERAPEUTICS, INC. | Todd S Thomson director, owner | $1.6M 280,000 shares | -24% | |
| 58Moderate | ACTUATE THERAPEUTICS, INC. | Aaron G.L. Fletcher director, owner | $500k 71,428 shares | +57% | |
| 58Moderate | ACTUATE THERAPEUTICS, INC. | Bios Equity COF, LP director, owner | $500k 71,428 shares | +57% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.